Moreover, six OSA patients (17.6% of the sample) showed pathological t-tau CSF levels (above cut-off > 375 pg/mL) and 9 patients (26.4%) showed pathological p-tau CSF levels (above cut-off > 52 pg/mL). This evidence concerns the gene MAPT and obstructive sleep apnea syndrome.